OR2J4P: A Potential Drug Target and Biomarker for Various Diseases

OR2J4P: A Potential Drug Target and Biomarker for Various Diseases

OR2J4P (OR6-9), a protein located in the endoplasmic reticulum (ER), has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique structure and subcellular localization make OR2J4P an attractive target for small molecules and antibodies that can modulate its activity and potentially interfere with its function.

OR2J4P is a 21-kDa protein that is expressed in most tissues and cells, including the brain, pancreas, and gastrointestinal tract. It is highly conserved across different species, with a calculated pI of 9.14. OR2J4P is a cytoplasmic protein that is predominantly localized to the endoplasmic reticulum, where it is involved in the quality control and degradation of various proteins. Its localization to the ER allows it to interact with a variety of different proteins, including those involved in cell signaling, protein synthesis, and intracellular signaling pathways.

OR2J4P functions as a negative regulator of the heat shock protein (HSP) gene. It interacts with the HSP70 protein and prevents it from being translated into functional HSPs. This interaction between OR2J4P and HSP70 has important implications for the regulation of protein synthesis and translation in cells. HSPs are known for their ability to withstand high levels of thermal stress and are often used as biomarkers for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. By regulating the activity of HSPs, OR2J4P may play a role in the pathogenesis of these diseases.

OR2J4P has also been shown to interact with the protein FERMT1, which is involved in cell division and maintenance. The interaction between OR2J4P and FERMT1 suggests that OR2J4P may be involved in regulating the activity of FERMT1 and in the regulation of cell division. This is of particular interest in the context of neurodegenerative diseases, where abnormal cell division and fusion may contribute to the development of neurodegeneration.

In addition to its potential involvement in the regulation of protein synthesis and cell division, OR2J4P has also been shown to play a role in the regulation of inflammation and immune responses. Its localization to the ER and its interaction with immune cell markers such as CD68 suggest that OR2J4P may be involved in the regulation of immune cell function and in the immune response. This is of particular interest in the context of autoimmune diseases, where abnormal immune responses can contribute to the development and progression of these diseases.

OR2J4P's unique structure and subcellular localization make it an attractive target for small molecules and antibodies that can modulate its activity. The ability to interact with a variety of different proteins and its subcellular localization to the ER make it a promising target for drugs that can modulate its function in a variety of diseases. Further research is needed to fully understand the role of OR2J4P in the regulation of protein synthesis, cell division, inflammation, and immune responses, as well as its potential as a drug target.

Protein Name: Olfactory Receptor Family 2 Subfamily J Member 4 Pseudogene

The "OR2J4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2J4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P